Hypertension
Conditions
Interventions
Experimental group:Using the same arm sequential method, the observer first used the control group to measure (using a double stethoscope at the same time), and then used YE990 to measure, alternating
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Women in the second and third trimesters of pregnancy (mid-pregnancy: 13 weeks - 27 weeks of gestation; late-pregnancy: 28 weeks and beyond). (2) Age distribution: The age of the subjects is over 18 years old. (3) Blood pressure distribution: At least 15 subjects have normal blood pressure (systolic blood pressure = 140 mmHg and/or diastolic blood pressure>=90 mmHg, and no proteinuria > 300 mg in 24 hours); at least 15 subjects have preeclampsia (systolic blood pressure>=140 mmHg and/or diastolic blood pressure >= 90 mmHg, accompanied by proteinuria, and proteinuria > 300 mg in 24 hours). (4) Voluntary participation in this clinical trial and signing the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with mental disorders or those who cannot cooperate calmly; (2) Those undergoing dialysis treatment or taking anticoagulant drugs, antiplatelet drugs, steroids and other medications; (3) Those with arrhythmia (such as atrial fibrillation, etc.); (4) Those whose arm circumference exceeds the size of the cuff; (5) Diabetic patients; (6) Those whose reference blood pressure (R1, R2, R3) has a significant difference with systolic blood pressure > 12 mmHg and diastolic blood pressure > 8 mmHg; (7) Those considered unsuitable by the researchers to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard deviation; | — |
Countries
China
Contacts
Public ContactZongzhi Yin
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed